![Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. - Abstract - Europe PMC Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3717945/bin/oncotarget-03-1068-g004.jpg)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. - Abstract - Europe PMC
![Phosphoproteomics Profiling Defines a Target Landscape of the Basophilic Protein Kinases AKT, S6K, and RSK in Skeletal Myotubes | Journal of Proteome Research Phosphoproteomics Profiling Defines a Target Landscape of the Basophilic Protein Kinases AKT, S6K, and RSK in Skeletal Myotubes | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.2c00505/asset/images/medium/pr2c00505_0008.gif)
Phosphoproteomics Profiling Defines a Target Landscape of the Basophilic Protein Kinases AKT, S6K, and RSK in Skeletal Myotubes | Journal of Proteome Research
Phosphoproteomics Profiling Defines a Target Landscape of the Basophilic Protein Kinases AKT, S6K, and RSK in Skeletal Myotubes | Journal of Proteome Research
![Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry | Science Signaling Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry | Science Signaling](https://www.science.org/cms/10.1126/scisignal.aaa3139/asset/f51b0f96-b353-481b-a3e5-93dc96cc128b/assets/graphic/8_rs6_f3.jpeg)